San Diego-based NuVasive, Inc. has announced that the company’s SpineTRACK Registry has reached a major enrollment milestone of 10,000 patients from more than 50 surgeons in the U.S.
NuVasive SpineTRACK Registry: 10,000 Patients and Counting!
1 min read Premium comments
#nuvasiveSecondary#spinetrack
“We are proud to be a part of this important spine outcomes registry,” said Adam S. Kanter, M.D., University of Pittsburgh Medical Center (UPMC) Chief of Spine.
“SpineTRACK has become an integral part of our practice here at UPMC and helps us better understand and meet the needs of our patients. With the rapidly changing healthcare landscape and growing importance of data collection, SpineTRACK has enabled us to record and report our patients’ outcomes to provide the best care to our patients, accomplish our academic and research goals, and promote cost-effective strategies to our health system and administrators in support of value-based policy conception and implementation.”
“Incorporating SpineTRACK at UPMC has proven to be a winning addition for all involved: the patient, the surgeon, the hospital and the health plan.”
Asked what makes this registry different, Matt Link, executive vice president, strategy, technology and corporate development for NuVasive, told OTW, “SpineTRACK is one of the most comprehensive solutions that includes both surgical and non-surgical patients.”
“While SpineTRACK is a NuVasive-sponsored Registry, it is implant agnostic, allowing all spine practices to participate regardless of products used.”
“The recent Qualified Clinical Data Registry (QCDR) designation is also a differentiator and a value-add for practices and eligible clinicians.”
“SpineTRACK can now submit quality metrics to the Centers for Medicare and Medicaid Services (CMS) to fulfill Merit-based Incentive Payment System (MIPS) reporting requirements to maximize future payment adjustments. The combination of all of these features truly differentiates SpineTRACK from other spine registries.”
“SpineTRACK serves as a quality improvement tool with the goal to track treatment and outcomes data to improve the quality of overall care. With that in mind, we expect to see the number of participants grow each year and include data from as many spine focused practices and hospital systems across the country as possible.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.